| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |